A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma. - Witzig TE; Laumann KM; Lacy MQ; Hayman SR; Dispenzieri A; Kumar S; Reeder CB; Roy V; Lust JA; Gertz MA; Greipp PR; Hassoun H; et al. (Leukemia, 2013)